Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Soligenix, Inc.
Almost a third of Medicare drug plans are expected to offer the insulin demonstration next year, while almost none have signed up for the payment ‘modernization’ demo, under which plans would be at more risk for spending during the catastrophic phase. The Centers for Medicare and Medicaid Services also announces basic Part D premiums will average $30.50 for 2021.
As expected, the National Medical Products Administration has issued four draft subsidiary regulations in rapid succession since publishing China’s new, finalized framework regulation for cosmetic products at the end of June. The documents include Technical Guidelines for Cosmetic Safety Assessment, a topic on which industry has been eagerly awaiting clarity.
Unilever’s leadership is optimistic about its enormously expanded hygiene business – both skin cleansing and home cleaning – inasmuch as it doubts that a full COVID-19 recovery is in sight. The firm launched hand sanitizers in 65 new markets in just five months, helping to offset plunging sales in other areas of its business that were heavily impacted by lockdowns around the world.
“How well do we understand the complex sector that supports every facet of our life?” asks Cosmetics Europe’s website for the “Essentials for Daily Life” film series co-developed with the trade association’s members in partnership with BBC StoryWorks Commercial Productions.
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Biological Therapeutics, Inc.
- DOR BioPharma, Inc.
- Endorex Corporation
- Enteron Pharmaceuticals
- Immunotherapeutics Inc.